General MedicationsINJECTIONGeneric
GANCICLOVIR SODIUM
GANCICLOVIR SODIUM
Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview GANCICLOVIR SODIUM is listed in Drugs@FDA under application 212001 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient GANCICLOVIR SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor CUSTOPHARM INC Submission history Latest submission status date: 2019-06-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview GANCICLOVIR SODIUM is listed in Drugs@FDA under application 212001 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GANCICLOVIR SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor CUSTOPHARM INC Submission history Latest submission status date: 2019-06-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.